Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression.
Stearns ME, Fudge K, Garcia F, Wang M. Stearns ME, et al. Invasion Metastasis. 1997;17(2):62-74. Invasion Metastasis. 1997. PMID: 9561025
RPS2: a novel therapeutic target in prostate cancer.
Wang M, Hu Y, Stearns ME. Wang M, et al. Among authors: stearns me. J Exp Clin Cancer Res. 2009 Jan 12;28(1):6. doi: 10.1186/1756-9966-28-6. J Exp Clin Cancer Res. 2009. PMID: 19138403 Free PMC article.
c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer.
Amatangelo MD, Goodyear S, Varma D, Stearns ME. Amatangelo MD, et al. Among authors: stearns me. Carcinogenesis. 2012 Oct;33(10):1965-75. doi: 10.1093/carcin/bgs227. Epub 2012 Jul 12. Carcinogenesis. 2012. PMID: 22791812 Free PMC article.
Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors.
Stearns ME, Wang M. Stearns ME, et al. Transl Oncol. 2011 Jun;4(3):147-56. doi: 10.1593/tlo.10286. Epub 2011 Jun 1. Transl Oncol. 2011. PMID: 21633670 Free PMC article.
Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
Wang M, Hu Y, Amatangelo MD, Stearns ME. Wang M, et al. Among authors: stearns me. Mol Cancer Res. 2011 Jan;9(1):36-50. doi: 10.1158/1541-7786.MCR-10-0158. Epub 2010 Dec 8. Mol Cancer Res. 2011. PMID: 21148031 Free article. Retracted.
Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.
Stearns ME, Amatangelo MD, Varma D, Sell C, Goodyear SM. Stearns ME, et al. Am J Pathol. 2010 Dec;177(6):3169-79. doi: 10.2353/ajpath.2010.100330. Epub 2010 Oct 22. Am J Pathol. 2010. PMID: 20971741 Free PMC article.
Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor.
Dolloff NG, Shulby SS, Nelson AV, Stearns ME, Johannes GJ, Thomas JD, Meucci O, Fatatis A. Dolloff NG, et al. Among authors: stearns me. Oncogene. 2005 Oct 13;24(45):6848-54. doi: 10.1038/sj.onc.1208815. Oncogene. 2005. PMID: 16007172 Free PMC article.
Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME, Kim G, Garcia F, Wang M. Stearns ME, et al. Mol Cancer Res. 2004 Jul;2(7):403-16. Mol Cancer Res. 2004. PMID: 15280448
CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells.
Shulby SA, Dolloff NG, Stearns ME, Meucci O, Fatatis A. Shulby SA, et al. Among authors: stearns me. Cancer Res. 2004 Jul 15;64(14):4693-8. doi: 10.1158/0008-5472.CAN-03-3437. Cancer Res. 2004. PMID: 15256432
Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis.
Stearns ME, Wang M, Hu Y, Kim G, Garcia FU. Stearns ME, et al. Lab Invest. 2004 Jun;84(6):785-95. doi: 10.1038/labinvest.3700075. Lab Invest. 2004. PMID: 15107801
84 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page